GSK vs SBFG · P/E 13, $103.31B cap vs P/E 8.8, rev $39.1M
GlaxoSmithKline PLC ADR (GSK) versus SB Financial Group Inc (SBFG) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
SB Financial Group Inc (SBFG) is a banks - regional company listed on NASDAQ.
GSK does not have a complete income-statement cache yet.
Latest reported SBFG revenue for 2026-06-30 was $39.1M. Net income was $8.8M. SBFG currently screens at market cap $141.3M and trailing P/E 8.8.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. SBFG currently screens at market cap $141.3M and trailing P/E 8.8.
Not investment advice. Open the GSK and SBFG stock pages for the full models.
Not investment advice.